SCHEMBL10037385

SCHEMBL10037385

Cc1c(C2(c3ccccc3O)c3ccccc3N(c3ccccc3)c3ccccc32)ccc2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.35
CYP1A2 P05177 2/20 0.34
CYP2A6 P11509 1/20 0.34
TSHR P16473 1/20 0.34
MAPT P10636 5/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPK1 P28482 1/20 0.34
EGLN1 Q9GZT9 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
HTT P42858 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
PTPN22 Q9Y2R2 1/20 0.31
PKM P14618 2/20 0.31
HSD17B10 Q99714 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
TNNI3 P19429 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3199631 0.80 EGLN1 (0.36) CYP1A2MAPK1EGLN1ALDH1A1SMN1; SMN2
SCHEMBL3227987 0.80 EGLN1 (0.33) CYP1A2EGLN1ALDH1A1HPGDNPSR1
SCHEMBL3176253 0.77 TP53 (0.34) KDM4ECYP1A2MAPTEGLN1ALDH1A1
SCHEMBL3186198 0.76 ESR1 (0.36) KDM4ECYP1A2MAPTMEN1KMT2A
SCHEMBL15030819 0.75 KDM4E (0.35) KDM4ECYP1A2CYP2A6TSHRMAPT
SCHEMBL10037546 0.73 ALDH1A1 (0.33) KDM4ECYP1A2TSHRMAPTMAPK1
SCHEMBL20202064 0.72 ALDH1A1 (0.44) CYP1A2MEN1KMT2AMAPK1EGLN1
SCHEMBL10037388 0.72 KDM4E (0.34) KDM4ECYP1A2MAPTMEN1KMT2A
SCHEMBL15030782 0.71 KDM4E (0.33) KDM4EMAPTMEN1KMT2AMAPK1
SCHEMBL2754783 0.70 ALDH1A1 (0.39) KDM4ECYP1A2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120001537-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001537-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME OR10J3, ORC3, PIEZO1 KDM4E 1720/4885CYP1A2 2391/4885CYP2A6 3370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.